Macular / Foveal Translocation — CPB 0409 | AETNA Coverage Update

Aetna modified CPB 0409 covering macular/foveal translocation, effective September 26, 2025. Here's what billing teams need to know.

Aetna, a CVS Health company, updated Clinical Policy Bulletin 0409, which governs the macular/foveal translocation coverage policy for retinal conditions including age-related macular degeneration (ICD-10 H35.30–H35.3293) and retinal neovascularization (H35.51–H35.59). This policy revision affects ophthalmology and retinal surgery billing teams billing for translocation procedures under these diagnoses. Review your claim submissions and documentation practices before the September 26, 2025 effective date.

Quick-Reference Table

Aetna Macular/Foveal Translocation Coverage Criteria and Medical Necessity Requirements 2025

The CPB 0409 Aetna system policy addresses macular and foveal translocation — surgical procedures that physically move the macula away from damaged subretinal tissue to restore or preserve central vision. These procedures are performed almost exclusively in patients with advanced age-related macular degeneration or significant retinal neovascularization that has not responded to other treatment.

Aetna's coverage policy for macular/foveal translocation is narrow by design. Medical necessity for these procedures is difficult to establish, and the clinical threshold Aetna applies reflects that. Your billing team should treat any claim under this policy as one requiring tight documentation — the diagnosis alone does not drive coverage.

The diagnosis codes that anchor this policy span a wide range. Age-related macular degeneration codes run from H35.30 through H35.3293, covering unspecified through highly specified AMD presentations including dry and wet forms, with and without pigment epithelial detachment. Retinal neovascularization codes H35.51 through H35.59 cover laterality and stage variations. Getting the most specific code your documentation supports is not optional here — it's the difference between a clean claim and a claim denial.

Prior authorization almost certainly applies to any macular/foveal translocation claim under Aetna. These are high-cost, high-complexity surgical procedures. If your team is submitting without confirming prior auth requirements for the specific plan, stop now and verify. A missing prior authorization on a surgical retinal claim is one of the most expensive avoidable denials in ophthalmology billing.

Reimbursement for translocation procedures is significant, which is exactly why Aetna scrutinizes these claims closely. The medical necessity criteria in the updated policy reflect that scrutiny. Your documentation needs to show the clinical rationale clearly — what other treatments were tried, why translocation is indicated, and which specific diagnosis applies.

Aetna Macular/Foveal Translocation Exclusions and Non-Covered Indications

Macular and foveal translocation procedures have a long history of being considered experimental or investigational by payers, and Aetna's position has not been universally favorable. This is similar to how Aetna has treated other complex retinal interventions — coverage exists, but only under tightly defined circumstances.

The real issue here is that the underlying diagnoses (AMD and retinal neovascularization) are common, but the surgical procedure used to treat them through translocation is not. Billing teams sometimes assume that a covered diagnosis equals a covered procedure. With CPB 0409, that assumption will generate denials.

If the treating physician's documentation doesn't explicitly tie the clinical presentation to the specific covered indication — with detail on prior treatment failure, visual acuity findings, and imaging results — Aetna will push back. The diagnosis codes H35.30–H35.3293 and H35.51–H35.59 are necessary but not sufficient for coverage. The clinical record has to do the work.

Coverage Indications at a Glance

Aetna Macular/Foveal Translocation Billing Guidelines and Action Items 2025

The effective date is September 26, 2025. That's your deadline for getting your house in order. Here's what to do now.

CPT, HCPCS, and ICD-10 Codes for Macular/Foveal Translocation Under CPB 0409

The policy data for CPB 0409 does not list specific CPT or HCPCS procedure codes. The applicable codes provided are ICD-10-CM diagnosis codes only. Your billing team should confirm the correct CPT codes for macular and foveal translocation procedures directly with the treating physician and verify coverage by calling Aetna's provider line or checking the CPB 0409 source document.

Key ICD-10-CM Diagnosis Codes

Use the most specific code your documentation supports within the H35.30–H35.3293 range for AMD. For retinal neovascularization, laterality matters — don't default to H35.54 (unspecified eye) when the record clearly documents right or left eye involvement.